Effect of recombinant interferon-gamma on protein content, phagocytic, and cytotoxic activity of mouse peritoneal macrophages
- PMID: 3132510
- DOI: 10.1089/jir.1988.8.169
Effect of recombinant interferon-gamma on protein content, phagocytic, and cytotoxic activity of mouse peritoneal macrophages
Abstract
We have studied the effect of recombinant murine interferon-gamma (rMuIFN-gamma) on the protein content, phagocytic activity, and cytotoxicity of mouse peritoneal macrophages (MPM). The aim of this study was to see whether rMuIFN-gamma alone could influence these parameters of MPM activity or if an additional stimulus, like elicitation or cultivation with lipopolysaccharide (LPS), was required. The MPM cultures were treated with rMuIFN-gamma for 24, 48, or 72 h. Generally, rMuIFN-gamma treatment of the cultures increased the protein content of the MPM. MPM were generally cytotoxic and they phagocytized IgG-opsonized Escherichia coli under the experimental conditions of this study. The effects of rMuIFN-gamma on phagocytic and cytotoxic activities were complex and highly dependent on the dose and length of treatment. Low or high concentrations may exert opposite effects on the same functions. Addition of a low dose of LPS to the cultures did not generally amplify the rMuIFN-gamma-induced alterations of MPM activities. However, the combination of LPS, high doses of rMuIFN-gamma, and long incubation time reduced the protein content, suppressed the phagocytic activity, and negatively influenced the viability of the MPM. Thioglycolate-elicited MPM had a higher baseline activity than resident MPM, but the rMuIFN-gamma effect on elicited MPM was parallel to the effect on resident MPM.
Similar articles
-
Synergistic induction of cytotoxicity in macrophages by murine interferon-gamma and biological response modifiers derived from microorganisms.Cancer Immunol Immunother. 1986;23(1):41-5. doi: 10.1007/BF00205553. Cancer Immunol Immunother. 1986. PMID: 3094943 Free PMC article.
-
Tumoricidal activity and cytokine secretion by tumor-infiltrating macrophages.Int J Cancer. 1991 Jul 9;48(5):704-8. doi: 10.1002/ijc.2910480513. Int J Cancer. 1991. PMID: 1906430
-
Treatment of murine macrophages with murine interferon-gamma and tumour necrosis factor-alpha enhances uptake and intracellular killing of Pseudomonas aeruginosa.Clin Exp Immunol. 1993 Aug;93(2):165-71. doi: 10.1111/j.1365-2249.1993.tb07960.x. Clin Exp Immunol. 1993. PMID: 8348741 Free PMC article.
-
Augmentation by bacterial lipopolysaccharide of antitumor potency of murine recombinant interferon-gamma against Lewis lung adenocarcinoma.Jpn J Cancer Res. 1986 Feb;77(2):212-8. Jpn J Cancer Res. 1986. PMID: 3082834
-
Gamma interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state.Infect Immun. 1993 Apr;61(4):1468-73. doi: 10.1128/iai.61.4.1468-1473.1993. Infect Immun. 1993. PMID: 8454351 Free PMC article.
Cited by
-
Biological basis for the clinical use of interferon.Gut. 1993;34(2 Suppl):S74-6. doi: 10.1136/gut.34.2_suppl.s74. Gut. 1993. PMID: 7686123 Free PMC article. Review.